Disclosures for "Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders ")
-
Dr. Guasp has nothing to disclose.
-
Mireia Rosa Justicia has nothing to disclose.
-
Amaia Muñoz-Lopetegi has nothing to disclose.
-
Dr. Martinez-Hernandez has nothing to disclose.
-
Dr. Armangue has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Armangue has received research support from ISCIII-FEDER; PI18-00486 and PI21/00316, PERIS Generalitat Catalunya (SLT006/17/00362); Pablove Foundation (689368), Fundació Marató de TV3 (37/C/2021) Torrons Vicens Foundation (PFNR0144), 2021 Invest AEP.
-
Gisela Sugranyes has nothing to disclose.
-
Dr. Stein has nothing to disclose.
-
Laia Prades has nothing to disclose.
-
Ms. Arino has nothing to disclose.
-
The institution of Jesús Planagumà has received research support from Spanish ministry of health/ISCIII.
-
Dr. De la Serna has nothing to disclose.
-
Dr. Escudero has nothing to disclose.
-
Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merci. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbot. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
-
Raquel Sánchez-Valle has nothing to disclose.
-
Joan Santamaria, MD has nothing to disclose.
-
The institution of Albert Compte has received research support from Instituto de Salud Carlos III. The institution of Albert Compte has received research support from La Caixa Foundation. The institution of Albert Compte has received research support from Ministerio de Ciencia e Innovación.
-
Josefina Castro-Fornieles has nothing to disclose.
-
Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.